Tempest Therapeutics, Inc. (TPST)
0.89
-0.02
(-2.08%)
USD |
NASDAQ |
Sep 10, 11:11
Tempest Therapeutics Total Liabilities (Quarterly) : 10.72M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.72M |
| March 31, 2026 | 9.926M |
| December 31, 2025 | 12.46M |
| September 30, 2025 | 10.78M |
| June 30, 2025 | 14.70M |
| March 31, 2025 | 21.03M |
| December 31, 2024 | 24.90M |
| September 30, 2024 | 22.38M |
| June 30, 2024 | 25.23M |
| March 31, 2024 | 23.75M |
| December 31, 2023 | 24.84M |
| September 30, 2023 | 25.18M |
| June 30, 2023 | 25.73M |
| March 31, 2023 | 26.36M |
| December 31, 2022 | 27.98M |
| September 30, 2022 | 36.40M |
| June 30, 2022 | 36.42M |
| March 31, 2022 | 37.60M |
| December 31, 2021 | 37.12M |
| September 30, 2021 | 23.61M |
| June 30, 2021 | 27.38M |
| March 31, 2021 | 6.079M |
| December 31, 2020 | 4.949M |
| September 30, 2020 | 9.024M |
| June 30, 2020 | 12.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.41M |
| December 31, 2019 | 15.10M |
| September 30, 2019 | 13.65M |
| June 30, 2019 | 13.30M |
| March 31, 2019 | 10.62M |
| December 31, 2018 | |
| September 30, 2018 | 4.323M |
| June 30, 2018 | 5.323M |
| March 31, 2018 | 5.696M |
| December 31, 2017 | 8.555M |
| September 30, 2017 | 9.737M |
| June 30, 2017 | 12.74M |
| March 31, 2017 | 11.60M |
| December 31, 2016 | 14.32M |
| September 30, 2016 | 12.52M |
| June 30, 2016 | 12.16M |
| March 31, 2016 | 13.22M |
| December 31, 2015 | 11.76M |
| September 30, 2015 | 10.22M |
| June 30, 2015 | 7.747M |
| March 31, 2015 | 6.683M |
| December 31, 2014 | 10.25M |
| September 30, 2014 | 8.874M |
| June 30, 2014 | 7.132M |
| March 31, 2014 | 6.361M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.633M |
| Shareholders Equity (Quarterly) | -1.09M |
| Debt to Equity Ratio | -6.936 |
| Current Ratio | 0.3813 |
| Net Debt Paydown Yield | 6.25% |